Wells Fargo
IMMX icon

Wells Fargo’s Immix Biopharma IMMX Stock Holding History

Wells Fargo’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$156K Buy
+17,149
New +$126K ﹤0.01% 4847
2025
Q4 		– Sell
-330
Closed -$690 – 7232
2025
Q3 		$690 Hold
330
– – ﹤0.01% 6280
2025
Q2 		$683 Hold
330
– – ﹤0.01% 6346
2025
Q1 		$554 Hold
330
– – ﹤0.01% 6265
2024
Q4 		$726 Hold
330
– – ﹤0.01% 6287
2024
Q3 		$492 Hold
330
– – ﹤0.01% 6173
2024
Q2 		$653 Sell
330
-104
-24% -$239 ﹤0.01% 6123
2024
Q1 		$1.33K Buy
434
+43
+11% +$167 ﹤0.01% 6091
2023
Q4 		$2.71K Buy
391
+334
+586% +$1.51K ﹤0.01% 6048
2023
Q3 		$195 Buy
57
+15
+36% +$35 ﹤0.01% 6595
2023
Q2 		$113 Buy
42
+4
+11% +$8 ﹤0.01% 6840
2023
Q1 		$69 Buy
38
+1
+3% +$2 ﹤0.01% 7024
2022
Q4 		$85 Buy
37
+1
+3% +$1 ﹤0.01% 6836
2022
Q3 		$0 Sell
36
-34
-49% -$74 ﹤0.01% 6965
2022
Q2 		$0 Buy
70
+44
+169% +$86 ﹤0.01% 7111
2022
Q1 		$0 Buy
+26
New +$97 ﹤0.01% 7404

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Wells Fargo's IMMX Position: Q1 2026 in Review

Wells Fargo opened a new position in Immix Biopharma (IMMX) in Q1 2026: 17,149 shares worth $156K. The stake represents ﹤0.01% of the portfolio and ranks #4847 among its holdings. This is a return to the name: Wells Fargo previously reported a position in IMMX as recently as Q3 2025.

Wells Fargo first reported a position in IMMX in Q1 2022 and has held it in 16 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Wells Fargo held 17,149 shares of Immix Biopharma worth $156K as of Q1 2026.
  • Immix Biopharma was a new Wells Fargo position in Q1 2026.
  • Immix Biopharma made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4847 holding.
  • Wells Fargo first reported a position in Immix Biopharma in Q1 2022 and has held it in 16 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.